When Access Becomes Fatal: A Case Series of Anesthetic-Drug Suicides Among Anesthesiologists.

Anesthesiologists face a uniquely elevated risk of suicide, often through the misuse of anesthetic or centrally acting agents to which they have professional access. These deaths present substantial forensic challenges due to rapid drug metabolism, limited routine toxicology coverage, and the need for careful scene correlation. Our aim is to describe and compare the forensic, toxicological, and scene findings of three anesthesiologists who died by suicide through self-administration of anesthetic or centrally acting drugs and to highlight the implications for forensic investigation and prevention. This is a retrospective descriptive analysis study that was conducted using complete medicolegal autopsy files. Data included scene observations, external and internal examinations, radiologic findings, and comprehensive toxicology. Cases were synthesized into comparative tables to evaluate shared features, drug-selection patterns, and forensic signatures. The results showed that all three individuals died from drug-induced respiratory arrest following deliberate administration of anesthetic or sedative agents. Case 1 involved high-level propofol toxicity; case 2 demonstrated fentanyl with elevated morphine metabolites; and case 3 showed extreme multisubstance toxicity, including propofol, antidepressants, opioids, and adjunct pharmaceuticals. Scene findings were consistent with intentional preparation, and no traumatic injuries or natural disease were present. Toxicological interpretation required targeted analytical methods due to rapid postmortem drug redistribution and degradation. So in conclusion, these cases illustrate the distinctive forensic characteristics of suicide among anesthesiologists, where drug access and expertise strongly shape the method of death. Accurate interpretation requires integrated scene analysis, targeted toxicology, and awareness of the unique pharmacologic challenges associated with anesthetic agents. Enhanced drug-security measures, early mental-health intervention, and vigilance within anesthesiology departments are essential to reduce the occurrence of similar fatalities.